Abstract

ZFN, TALENs and CRISPR/Cas9 system have been used to generate point mutations and large fragment deletions and insertions in genomic modifications. CRISPR/Cas9 system is the most flexible and fast developing technology that has been extensively used to make mutations in all kinds of organisms. However, the most mutations reported up to date are small insertions and deletions. In this report, CRISPR/Cas9 system was used to make large DNA fragment deletions and insertions, including entire Dip2a gene deletion, about 65kb in size, and β-galactosidase (lacZ) reporter gene insertion of larger than 5kb in mouse. About 11.8% (11/93) are positive for 65kb deletion from transfected and diluted ES clones. High targeting efficiencies in ES cells were also achieved with G418 selection, 46.2% (12/26) and 73.1% (19/26) for left and right arms respectively. Targeted large fragment deletion efficiency is about 21.4% of live pups or 6.0% of injected embryos. Targeted insertion of lacZ reporter with NEO cassette showed 27.1% (13/48) of targeting rate by ES cell transfection and 11.1% (2/18) by direct zygote injection. The procedures have bypassed in vitro transcription by directly co-injection of zygotes or co-transfection of embryonic stem cells with circular plasmid DNA. The methods are technically easy, time saving, and cost effective in generating mouse models and will certainly facilitate gene function studies.

Highlights

  • Modified mice represent a powerful tool for dichotomizing gene functions [1,2]

  • Circular plasmids can mediate long range and high efficiency deletion in ES cells Recent in vitro studies suggest DIP2A to be the receptor of FSTL1 and mediate numerous FSTL1 biological functions [27,28]

  • Nucleofection of ES cells was first optimized by using supercoiled pCBh-enhanced green fluorescent protein (EGFP)-N1 plasmid

Read more

Summary

Introduction

Modified mice represent a powerful tool for dichotomizing gene functions [1,2]. Mice carrying targeted mutations are generated by homologous recombination [3]. The technology takes the advantage of cultured embryonic stem cells and chimera generation. The procedures are tedious, less cost-effective and time-consuming. Zinc-finger nucleases (ZFN) [4], transcription activator-like effector nucleases (TALENs) [5,6] and CRISPR/Cas system are recently developed technologies in genomic editing. Engineered ZFNs, TALENs and CRISPR/Cas have been successfully used to direct site-specific cleavage and mediate

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call